OMBAKAY
Live / Allowed — Third extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98388293
- Mark type
- Word mark
- Filed
- 02 Feb 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 26 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 3 GRANTED
- 16 Mar 2026 — SOU EXTENSION 3 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2025 — SOU EXTENSION 2 GRANTED
- 08 Sept 2025 — SOU EXTENSION 2 FILED
- 08 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED